exRNAdisease

Entry Detail

---



General Information

Database ID: exR0729515 RNA Name: hsa-miR-663a RNA Type: miRNA Chromosome: chr20 Starnd: - Coordinate: Start Site(bp): 26208243 End Site(bp): 26208264 External Links: hsa-miR-663a

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE54010 Description: miRNA expression profiles in the 19 candidate urines (prostate cancer, CaP, patients and non-cancer subjects with benign prostatic hyperplasia, BPH) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Advanced Prostate Cancer Case Sample: Advanced Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 7 Number of Control: 5 Number of Samples: 12

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand COL6A2 chr21 46098112 46132848 + KLC2 chr11 66257294 66267860 + REXO1 chr19 1815248 1848483 - MIDN chr19 1248553 1259140 + STK35 chr20 2101827 2177038 + MIGA2 chr9 129036621 129072082 + SRPRA chr11 126262938 126269144 - KDM2A chr11 67119263 67258082 + JUNB chr19 12791486 12793315 + GNB1 chr1 1785285 1891117 - SYVN1 chr11 65121780 65134533 - SCN1B chr19 35030470 35040449 + SMAD3 chr15 67063763 67195169 + HIF1AN chr10 100529072 100559998 + TNRC6A chr16 24610209 24827632 + ARHGAP1 chr11 46677080 46700619 - ARL8A chr1 202133404 202144743 - PPDPF chr20 63520765 63522206 + KMT5A chr12 123383773 123409353 + RTL8A chrX 135050932 135052196 - SOX12 chr20 325595 330224 + CYB5R3 chr22 42617840 42649392 - PRR12 chr19 49591182 49626439 + CAPN15 chr16 527712 554636 + DMWD chr19 45782947 45792845 - BOC chr3 113211003 113287459 + FAM83H chr8 143723933 143738234 - CLSTN1 chr1 9728926 9823984 - CALR chr19 12938578 12944489 + CMIP chr16 81445170 81711762 + miRNA targets: NA circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC008738.7 chr19 33207129 33207639 + AC020928.2 chr19 36773712 36775908 - AC069281.2 chr7 100572232 100578700 - AC234582.1 chr1 155195004 155205495 + AL137127.1 chr1 19072110 19075511 - AL355075.4 chr14 20343048 20343685 - AL356488.2 chr1 109100193 109100619 + GAS5 chr1 173858559 173868882 - MIR663AHG chr20 26167817 26251546 - NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - SNHG25 chr17 64145970 64146476 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE54010 Sample Source: Urine Source Fraction: Urine Platform: GPL15159 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1183 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted using RecoverAllTM Total Nucleic Acid Isolation kit (Life Technologies, Carlsbad, CA). RNA library preparation protocol: 400 ng of total RNA was labeled with cyanine 3-pCp using the Agilent miRNA Complete Labeling kit and hybridized to the array according to the manufacturer's protocol.

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA